-
ACLA Statement on President Biden’s Actions to Close Coverage Gaps for COVID-19 Testing
Washington, D.C. Following the Biden Administration’s new guidance on coverage requirements for COVID-19 testing, ACLA President Julie Khani released the following statement: “President Biden’s decisive ... Read More -
ACLA Letter To Senate Finance Committee On Xavier Becerra’s Nomination
-
ACLA Letter To Biden Administration On COVID Testing
-
ACLA Member Labs Surpass 100 Million COVID-19 Tests Performed
Association Outlines Key Priorities to Address Next Phase of the Pandemic WASHINGTON, D.C. – Members of the American Clinical Laboratory Association (ACLA) today surpassed 100 million ... Read More -
ACLA Letter to New York State on Executive Order
-
Connecting Patients with The Treatment They Need
Kavita Bhat, PhD, is the Vice President of Lab Operations at Myriad Neuroscience, a subsidiary of Myriad Genetics. In her role, Dr. Bhat works closely ... Read More -
ACLA Statement on President Biden’s Actions to Combat COVID-19
Washington, D.C. – Following President Biden’s actions announced today to combat the COVID-19 pandemic, ACLA President Julie Khani released the following statement: “We commend President Biden ... Read More -
Joint Letter on Cycle-Threshold Value Reporting
-
ACLA Statement on President-elect Biden’s American Rescue Plan
Washington, D.C. – In response to the release of President-elect Biden’s American Rescue Plan, ACLA President Julie Khani released the following statement: “ACLA members stand ready to ... Read More -
ACLA Statement on Year-End Funding Package
WASHINGTON, D.C. – As Congress nears a vote on year-end legislation to fund the government and support COVID-19 response efforts, ACLA President Julie Khani released the following ... Read More
